Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.45 USD | -1.43% | +2.37% | +107.83% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joel Lewis
CEO | Chief Executive Officer | 54 | 17-11-30 |
Jack Callicutt
DFI | Director of Finance/CFO | 56 | 13-06-30 |
Ezra R. lowe
CTO | Chief Tech/Sci/R&D Officer | - | - |
Pol Boudes
CTO | Chief Tech/Sci/R&D Officer | 67 | 20-03-01 |
Harold Shlevin
BRD | Director/Board Member | 75 | 12-09-30 |
Susan Thornton
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Freeman
BRD | Director/Board Member | 62 | 11-04-30 |
Benjamin Carson
BRD | Director/Board Member | 73 | Dec. 06 |
Gil Omenn
BRD | Director/Board Member | 83 | 14-09-22 |
Gilbert Amelio
BRD | Director/Board Member | 81 | 09-02-11 |
Harold Shlevin
BRD | Director/Board Member | 75 | 12-09-30 |
Dick Uihlein
CHM | Chairman | 79 | 17-12-13 |
Marc Rubin
BRD | Director/Board Member | 69 | 11-10-11 |
Kary Eldred
BRD | Director/Board Member | 50 | 17-12-31 |
Richard Zordani
BRD | Director/Board Member | 52 | 20-08-31 |
Elissa Schwartz
BRD | Director/Board Member | 54 | 20-08-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,235,000 | 0 | 0 | 67.53 % |
Stock B | 1 | 61,903,672 | 42,636,943 ( 68.88 %) | 0 | |
Stock C | 0 | 176 | 0 | 0 |
Company contact information
Galectin Therapeutics, Inc.
4960 Peachtree Industrial Boulevard Suite 240
30071, Norcross
+678 620 3186
http://www.galectintherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+107.83% | 214M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- GALT Stock
- Company Galectin Therapeutics Inc.